January 2026

2 January 2026

Hiring MSc Fresher in Quality Control at USV Private Limited

Support in sampling and testing of raw materials, finished products and stability analysis. Documentation: Maintaining accurate, real-time records of all analysis as per cGMP and GLP guidelines.

2 January 2026

Openings in QA, Production, Powder Processing at Ipca Laboratories

UG / PG in relevant field. Collecting and reviewing annual product data, preparing APQR reports, identifying trends, and helping for improvements.

2 January 2026

Hiring MPharm, BPharm, MSc in QC, Formulation & Development at Swiss Garniers

Swiss Garniers dynamic entities serve as the linchpin of numerous sectors, proffering unparalleled expertise, world-class infrastructure, and a rich reservoir of resources essential for the seamless translation of concepts into market-ready products.

2 January 2026

Multiple posts at Finecure Pharmaceuticals for MPharm, BPharm, MSc

Finecure Pharmaceuticals Limited is a leading manufacturer and marketer of Pharmaceutical formulations in several therapeutic segments in dosage forms of Tablets

2 January 2026

Interview for MPharm, BPharm, MSc, BSc in QA, QC, Production at BDR Pharmaceuticals

BDR Group of companies has grown steadily and become a house-hold name in the pharmaceutical Industry over the last 15 years

2 January 2026

NPPA Fixes Retail Prices for 37 New Drug Formulations, Caps Key Medicines

The National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 37 new drug formulations under the Drugs (Prices Control) Order (DPCO), 2013, through an order issued on December 24, 2025. The decision, published in the Gazette of India, aims to regulate the prices of commonly used medicines across therapeutic segments, while ensuring affordability and transparency for consumers.

2 January 2026

Aurobindo Pharma arm acquires Khandelwal Labs non-oncology business for ₹3,250 crore

Aurobindo Pharma Limited on January 1, 2026 informed stock exchanges that its wholly owned subsidiary, Auro Pharma Limited, has approved the acquisition of the non-oncology prescription formulations business of Khandelwal Laboratories